Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ENTX
ENTX logo

ENTX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Entera Bio Ltd (ENTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.350
1 Day change
10.66%
52 Week Range
3.220
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ENTX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near $1.22 with a weak technical setup, no recent news catalysts, no strong proprietary buy signal, and only a mildly supportive analyst rating versus a very low price target that still implies huge upside but lacks near-term confirmation. For an impatient buyer, this is not a strong entry today.

Technical Analysis

Current trend is weak to neutral-bearish. MACD histogram is below zero and expanding negatively, RSI_6 is 46.9, which is neutral, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is below the pivot at 1.262 and sitting near support at 1.193, with deeper support at 1.15. This suggests the stock is drifting lower rather than beginning a confirmed uptrend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is extremely call-skewed on open interest, but actual trading volume is zero, so the signal is thin and not very actionable. Implied volatility is extremely high at 893.49, which suggests the market expects large swings but not necessarily a directional edge. With no meaningful volume and no confirmed momentum, options data does not strengthen a buy case.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
12

Positive Catalysts

  • ["H.C. Wainwright keeps a Buy rating and still sees upside with a $9 target, despite cutting it from $10.", "Very low open interest put-call ratio suggests bullish positioning in options open interest."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst.", "No AI Stock Picker signal today.", "No SwingMax signal recently.", "Technicals remain bearish with negative MACD momentum and weak moving-average structure.", "Hedge funds and insiders are both neutral, showing no meaningful accumulation signal.", "No recent congress trading data available.", "Extremely high implied volatility and zero option volume reduce the reliability of the options setup."]

Financial Performance

No usable latest-quarter financial snapshot was available because of a data error, so there is no confirmed financial growth trend to support a purchase decision. The latest quarter season cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment remains positive but slightly weaker: H.C. Wainwright lowered the price target to $9 from $10 while keeping a Buy rating on 2026-04-27. That is still constructive, but the cut in target suggests reduced conviction relative to before. Wall Street's pros view is that ENTX has meaningful upside potential if pipeline execution improves; the cons view is that the stock lacks current momentum, catalysts, and financial confirmation.

Wall Street analysts forecast ENTX stock price to rise
1 Analyst Rating
Wall Street analysts forecast ENTX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.220
sliders
Low
10
Averages
10
High
10
Current: 1.220
sliders
Low
10
Averages
10
High
10
H.C. Wainwright
Buy
to
Buy
downgrade
$10 -> $9
AI Analysis
2026-04-27
Reason
H.C. Wainwright
Price Target
$10 -> $9
AI Analysis
2026-04-27
downgrade
Buy
to
Buy
Reason
H.C. Wainwright lowered the firm's price target on Entera Bio to $9 from $10 and keeps a Buy rating on the shares.

People Also Watch